Frontlight ResearchEarly access
CompletedPhase 2
Thrombosomes® in Acute Thoracic Aortic Dissections
Key facts
- Who runs it
- Jakob Stensballe, MD, PhD
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 41 people enrolled
- Started
- 15 Mar 2023
- Ended
- 11 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Thrombosomes®
- Standard platelet concentrate
- Record updated
- 7 May 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patient eligible for emergency surgery on cardiopulmonary bypass pump for acute thoracic aortic dissections
- Age ≥ 18 years
Who cannot take part
- Withdrawal from active therapy
- Known hypersensitivity to TBX: the active substance, any of the excipients
- Pregnancy (non-pregnancy confirmed by patient being postmenopausal (women >55 years of age) or having a negative urine-hCG)
- Documented refusal of blood transfusion
- Aortic dissection due to trauma
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The hypothesis is that administration of Thrombosomes® (TBX®) as hemostatic support when terminating the cardiopulmonary bypass (CPB) in patients undergoing emergency surgery for acute thoracic aortic dissection (aTAD) is safe and least as effective when compared to standard Platelet Concentrates (stPC).
The 2 groups in the trial
- Thrombosomes®Treatment being tested
Thrombosomes® (TBX®) up to 3 doses
- Standard platelet concentrateExisting treatment, for comparison
Standard platelet concentrate up to 3 doses
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility and Safety of Thrombosomes® on Time to Hemostasis in Patients Undergoing Emergency Surgery for Thoracic Aortic Dissections - a Randomized, Controlled, Open-label Investigator-initiated Pilot Trial
- Record updated
- 7 May 2024